| Monitoring Heart Failure |
| Written by Kristi Runyon | |||
| Tuesday, 15 September 2009 11:27 | |||
Annually, 300,000 people in the U.S. die from heart failure complications. By the time symptoms of worsening disease develop, patients may require hospitalization for treatment. Researchers are testing an implantable wireless sensor that monitors pressure inside the pulmonary artery. Heart Failure The National Heart, Lung and Blood Institute estimates heart failure affects 5 million Americans. Annually, about 550,000 new cases are diagnosed in the U.S. and 300,000 people die from heart failure complications. The condition is more common in men, people over 65, African Americans and people who are overweight. The most common causes of heart failure are coronary artery disease, high blood pressure and diabetes. Monitoring Heart Failure Amish Desai, M.D., Interventional Cardiologist with Swedish Heart & Vascular Clinic in Seattle, says an important component of heart failure management is monitoring of fluid levels in the body. If the tissues retain too much fluid, the heart must work harder to pump blood to the lungs and to the body. In turn, that leads to symptoms, like shortness of breath and swelling in the legs and ankles. By the time the symptoms appear, the patient may require hospitalization. A Wireless Implant Once at home, a pressure reading is taken every morning. The patient lies on a bed and places a device, called a transducer, on the pillow. The pressure information from the implanted sensor is transmitted to the transducer, then sent over the internet to a database, enabling the physician to access the information. Desai says with the implanted sensor, doctors can see immediately if there are any changes in pressure, which would reflect changes in fluid volume. Small changes can be managed (often with medications or dietary adaptations) before the patient retains a significant amount of fluid or shows any symptoms. Ideally, the system will reduce the need for office visits, emergency room visits and hospitalization. The CardioMEMS sensor for heart failure is currently under study. The trial is called, CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients), and will involve 550 patients at 58 medical centers across the country.
For general information on heart failure: Research compiled and edited by Barbara J. Fister © 2009 Medstar Television, Inc. All Rights Reserved
Trackback ( 0 )
Trackback Link for This Article
|